L'avis favorable historique de l'EMA ouvre la voie à un accès direct sans prescription pour la pilule du lendemain ellaOne® dans toute l’Union Européenne, dès 2015

ellaOne® a été approuvée par le Comité des produits médicaux à usage humain (CHMP) de l’Agence européenne des produits de santé (EMEA). Il s’agit de la toute première décision de ce type concernant une contraception orale, qui pourrait être mise en application dans tous les pays membres de l’UE courant 2015, après une ultime ratification par la Commission européenne.

En savoir plus

Historic decision from the european commission grants 120 million women access to ellaOne® emergency contraceptive across the european union.

The European Commission, in a historic ruling, has authorised ellaOne (ulipristal acetate, 30mg), to be accessible direct from pharmacies without the need for a prescription from a doctor. This is the first ever decision of its type regarding any oral contraceptive product applicable to all EU member states, according to national implementation procedures. This new ruling will empower over 120 million women across the whole EU to gain direct access to emergency contraception.

Learn more

At HRA Pharma we dream of meeting unmet medical needs in women’s health and endocrinology

We dare to innovate to conquer unmet needs

And we share our values and victories throughout the world

WOMEN'S HEALTH

We dream to offer innovative treatments notably in the areas of women’s reproductive healthcare. Daring to break down barriers and share our products with women across the world.

ENDOCRINOLOGY

Our commitment to innovation drives us to push the boundaries of medical science to develop therapies that benefit patients afflicted by rare endocrine diseases.

news

  • 13/01/2015 1

    Historic decision from the European Commission grants 120 million women direct access to ellaOne® emergency contraceptive across the European Union. ...

  • 15/12/2014 2

    HRA Pharma announced that the European Commission has granted, on November 19th, 2014, a marketing authorisation for Ketoconazole HRA® (ketoconazole, ...

  • 21/11/2014 3

    Landmark recommendation from EMA paves the way for access without prescription to the ellaOne® morning-after pill across Europe in 2015. ...

closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?